pneumonia
lung
infect
involv
alveoli
caus
varieti
microb
includ
bacteria
virus
fungi
lead
infecti
caus
hospit
death
unit
state
unit
state
pneumonia
result
million
discharg
hospit
averag
length
stay
day
pneumonia
account
hospit
death
account
death
per
popul
pneumonia
continu
lead
killer
young
children
around
world
caus
death
children
age
month
year
instanc
pneumonia
attribut
selfinfect
one
type
microb
origin
nose
mouth
healthi
individu
typic
upper
airway
bacteri
resid
streptococcu
pneumonia
haemophilu
influenza
common
bacteria
caus
communityacquir
pneumonia
hospitalacquir
pneumonia
usual
caus
resist
bacteria
staphylococcu
aureu
klebsiella
pneumonia
pseudomona
aeruginosa
escherichia
coli
seriou
impair
immun
system
opportunist
microb
readili
appar
fungi
virus
mycobacteria
mani
mechan
use
lung
resist
infect
physic
mechan
structur
upper
airway
branch
bronchial
tree
sticki
mucou
layer
line
airway
cilia
propel
mucou
upward
cough
reflex
microb
reach
alveoli
immun
system
usual
abl
destroy
varieti
strategi
use
reduc
incid
pneumonia
element
healthi
lifestyl
reduc
incid
adequ
nutrit
dental
hygien
smoke
lung
diseas
impair
clearanc
mucou
aerob
exercis
deep
breath
maneuv
cough
assist
devic
facilit
expector
lung
hygien
immun
certain
microb
enhanc
immun
pneumonia
common
infect
parenchyma
lower
respiratori
tract
affect
age
popul
signific
morbid
mortal
associ
pneumonia
especi
young
elderli
popul
pneumonia
lead
caus
death
children
younger
year
age
worldwid
averag
yearli
incid
pneumonia
specif
communityacquir
pneumonia
per
incid
case
occur
winter
month
pass
person
person
viral
particl
respiratori
droplet
decis
treat
whether
admit
hospit
treat
outpati
potenti
prognosi
depend
upon
like
pathogen
current
clinic
pictur
case
pathogen
never
isol
suspect
prior
initi
treatment
pneumonia
classif
base
upon
varieti
factor
age
clinic
present
comorbid
well
histori
previou
hospit
admiss
resid
nurs
facil
best
approach
good
histori
physic
exam
combin
knowledg
common
caus
pneumonia
present
age
patient
seen
communityacquir
pneumonia
cap
must
distinguish
hospitalacquir
pneumonia
hap
healthcareassoci
pneumonia
hcap
ventilatorassoci
pneumonia
vap
treatment
start
addit
caus
pneumonia
must
determin
bacteri
viral
atyp
natur
treat
bacteri
pneumonia
specif
streptococcu
pneumonia
common
caus
pneumonia
across
age
certain
comorbid
risk
factor
see
footnot
tabl
age
greater
alcohol
abus
recent
antibiot
use
within
past
month
coexist
medic
diagnos
copd
chf
exposur
day
carenurs
home
child
adult
increas
likelihood
patient
may
ill
caus
bacteri
caus
pneumonia
may
requir
addit
differ
treatment
children
suspect
organ
caus
pneumonia
base
upon
age
child
birth
week
group
b
streptococcu
haemophilu
influenza
type
b
hib
listeria
monocytogen
cytomegaloviru
week
month
streptococcu
pneumonia
chlamydia
trachomati
respiratori
syncyti
viru
rsv
respiratori
virus
bordetella
pertussi
month
year
rsv
respiratori
virus
pneumonia
group
streptococci
year
pneumonia
mycoplasma
pneumonia
chlamydia
pneumonia
gener
principl
appli
adult
attempt
determin
like
organ
affect
patient
differ
organ
treatment
option
base
age
ill
patient
associ
risk
factor
see
footnot
tabl
locat
treatment
outpati
vs
inpati
vs
intens
care
unit
icu
outpati
risk
factor
pneumonia
pneumonia
esp
age
group
c
pneumonia
h
influenza
respiratori
virus
outpati
risk
factor
pneumonia
pneumonia
c
pneumonia
mix
bacteria
viru
atyp
h
influenza
legionella
respiratori
virus
fungi
inpati
nonicu
pneumonia
h
influenza
pneumonia
c
pneumonia
mix
bacteria
viru
atyp
respiratori
virus
legionella
mycobacterium
tuberculosi
pneumocysti
jirovecii
inpati
requir
icu
admiss
pneumonia
includ
drug
resist
legionella
h
influenza
gramneg
enter
organ
aureu
pneumonia
pseudomona
sp
respiratori
virus
c
pneumonia
tuberculosi
fungi
common
present
symptom
immunolog
compet
patient
includ
sudden
recent
onset
cough
purul
sputumdyspneafev
chillspleurit
chest
pain
import
inform
obtain
patient
regard
recent
hospit
current
resid
locat
elderli
patient
medic
histori
recent
medic
antibiot
use
physic
exam
find
vari
one
patient
anoth
let
alon
one
age
popul
anoth
follow
exam
find
consist
find
patient
pneumonia
vital
sign
temperatur
tachypnea
breathsmin
tachycardia
beatsmin
decreas
puls
oximetri
read
room
air
gener
septic
appear
respiratori
exam
increas
tactil
fremituscrackl
egophonydul
percussiondecreas
breath
soundsair
movement
make
sure
look
red
flag
patient
present
pneumoniatyp
symptom
red
flag
symptom
accessori
muscl
use
sternal
retract
gruntingnas
flaringalt
mental
statusapnea
presenc
symptom
may
indic
sever
infect
requir
admiss
intens
care
unit
chest
radiographi
test
choic
patient
clinic
suspect
cap
presenc
infiltr
consolid
xray
requir
diagnosi
cap
fig
chest
radiographi
perform
patient
least
one
follow
abnorm
vital
sign
temperatur
heart
rate
beatsminrespiratori
rate
breathsmin
patient
least
two
clinic
find
decreas
breath
soundscrackl
rale
absenc
asthma
routin
laboratori
test
requir
establish
diagnosi
outpati
set
laboratori
test
recommend
differ
though
patient
requir
admiss
hospit
intens
care
unit
treatment
includ
complet
blood
count
cbc
basic
metabol
panel
bmp
sputum
gram
stain
cultureblood
cultur
drawn
two
separ
sitesarteri
blood
ga
abg
patient
experienc
respiratori
distress
patient
evalu
hap
hcap
vap
lower
respiratori
tract
specimen
cultur
specimen
come
expector
sputum
bronchoalveolar
lavag
bal
patient
present
sever
cap
special
test
urinari
antigen
streptococcu
pneumonia
legionella
pneumonia
serogroup
approv
test
provid
rapid
result
high
specif
sensit
therebi
prompt
target
treatment
follow
might
consid
differenti
base
upon
patient
sign
symptom
comorbid
influenzavir
pneumoniaatyp
pneumoniaacut
bronchitiscopd
exacerbationcongest
heart
failur
chf
pleural
effusionpulmonari
embol
import
first
determin
make
treatment
patient
pneumonia
regard
sever
ill
direct
siteofcar
decis
hospit
vs
outpati
icu
vs
medic
ward
two
score
system
assist
decis
hospit
pneumonia
sever
index
psi
confus
uremia
respiratori
rate
low
blood
pressur
age
year
greater
use
one
criteria
addit
clinic
pictur
patient
help
guid
appropri
medic
site
treatment
decid
admit
patient
hospit
treatment
next
decis
made
whether
patient
need
icu
treatment
accord
infecti
diseas
societi
americaamerican
thorac
societi
sever
clinic
criteria
consid
icu
admiss
meet
three
follow
tachypnea
rr
ratio
infiltratesalt
mental
statusconfusionbun
uremia
white
blood
cell
count
platelet
count
ktemperatur
shock
requir
aggress
fluid
hydrat
locat
treatment
guid
antibiot
choic
treatment
case
difficult
establish
exact
organ
affect
patient
therefor
empir
antibiot
therapi
guidelin
establish
tabl
review
like
organ
found
adult
base
patient
age
treatment
locat
provid
recommend
empir
therapi
current
dose
recommend
bacteri
pneumonia
typic
treat
minimum
day
length
treatment
depend
upon
degre
ill
present
age
comorbid
initi
respons
whether
patient
hospitalizedicu
attent
direct
monitor
length
intraven
therapi
recogn
switch
oral
therapi
patient
clinic
improv
requir
intervent
maintain
hemodynam
stabil
hesh
safe
switch
oral
therapi
complet
cours
treatment
addit
follow
updat
guidelin
also
import
awar
local
epidemiolog
data
well
potenti
antibioticresist
chang
typic
bacteri
pneumonia
treatment
differ
antibiot
choic
made
patient
present
hcap
hap
vap
multidrugresist
pathogen
must
consid
infect
treat
accordingli
decreas
patient
chanc
becom
ill
pneumonia
import
part
primari
care
physician
job
counsel
patient
smoke
import
smoke
cessationencourag
schedul
vaccinationseduc
patient
accept
hand
hygien
standard
wash
hand
regularli
soap
warm
water
least
sdisinfect
frequent
touch
surfacesteach
cough
etiquett
cover
mouth
nose
tissu
cough
sneez
put
use
tissu
wast
basketif
tissu
teach
cough
sneez
upper
sleev
elbow
hand
vaccin
prevent
ill
long
proven
effect
overal
patient
popul
morbid
mortal
risk
infect
common
bacteri
pneumonia
streptococcu
pneumonia
decreas
immun
accord
center
diseas
control
follow
vaccin
import
prevent
pneumonia
pneumococc
haemophilu
influenza
type
bpertussi
whoop
cough
influenza
flu
yearlymeasl
pneumonia
consid
common
atyp
pathogen
communityacquir
pneumonia
cap
preval
pneumonia
adult
pneumonia
rang
outbreak
occur
institut
set
school
militari
base
usual
transmit
close
person
person
contact
via
respiratori
droplet
averag
incub
period
around
week
infect
tend
occur
fall
winter
onset
symptom
typic
gradual
cours
sever
day
common
symptom
includ
sore
throat
muscl
pain
headach
malais
chill
patient
also
complain
cough
initi
dri
becom
product
cours
infect
cough
typic
wors
night
sinu
pressur
otalgia
also
occur
lung
exam
normal
initi
examin
develop
scatter
rale
wheez
progress
extrapulmonari
complic
includ
maculopapular
rash
arthralgia
asept
mening
transvers
myelopathi
syndrom
sinc
progress
gradual
patient
may
seek
medic
attent
day
week
obtain
chest
radiograph
may
reveal
infiltr
may
promin
ill
present
least
week
cultur
throat
nasopharyng
pleural
fluid
consid
gold
standard
diagnosi
cold
agglutinin
test
use
well
usual
appear
end
first
week
ill
around
patient
pneumonia
posit
cold
agglutinin
develop
serolog
respons
pneumonia
serolog
obtain
complement
fixat
cf
enzym
immunoassay
eia
macrolid
erythromycin
azithromycin
tetracyclin
doxycyclin
fluoroquinolon
levofloxacin
moxifloxacin
typic
therapi
use
treat
pneumonia
macrolid
particularli
azithromycin
tend
activ
pneumonia
vitro
studi
durat
antibiot
treatment
typic
day
azithromycin
day
tetracyclin
fluoroquinolon
use
appropri
hand
hygien
cough
etiquett
chlamydia
gramneg
oblig
intracellular
organ
includ
chlamydia
trachomati
chlamydophila
formerli
chlamydia
pneumonia
chlamydophila
psittaci
c
trachomati
gener
present
genit
tract
ocular
infect
latter
two
present
atyp
pneumonia
around
case
communityacquir
pneumonia
cap
relat
c
pneumonia
along
atyp
pneumonia
patient
present
product
cough
sore
throat
sinu
congest
malais
patient
psittacosi
caus
c
psittaci
tend
histori
exposur
infect
bird
often
present
young
middleag
adult
symptom
includ
abrupt
fever
headach
dri
cough
myalgia
malais
chest
radiograph
may
show
infiltr
diagnosi
oropharyng
swab
use
cultur
chlamydophila
speci
serolog
test
eia
polymeras
chain
reaction
pcr
use
well
chest
radiograph
reveal
interstiti
lobar
infiltr
c
pneumonia
c
psittaci
diagnos
serolog
test
doxycyclin
mg
oral
twice
daili
day
treatment
choic
c
pneumonia
c
psittaci
macrolid
azithromycin
use
well
usual
choic
empir
treatment
atyp
pneumonia
counsel
patient
import
hand
hygien
cough
etiquett
immunocompet
adult
commonli
seen
viru
influenza
children
respiratori
syncyti
viru
rsv
influenza
affect
us
popul
annual
result
hospit
death
rsv
account
pneumonia
bronchiol
infant
common
virus
adenoviru
parainfluenza
less
common
virus
includ
human
metapneumoviru
herp
simplex
viru
varicellazost
viru
sarsassoci
coronaviru
measl
viru
influenza
rsv
droplet
fomit
transmiss
common
method
transmiss
influenza
incub
period
day
viral
shed
begin
appear
symptom
within
first
h
inocul
viral
shed
peak
second
day
healthi
adult
longer
detect
day
later
children
immunocompromis
adult
prolong
viral
shed
occur
day
rsv
viral
shed
mean
day
rang
day
infant
rsv
initi
present
rhinorrhea
decreas
appetit
follow
cough
within
day
soon
cough
sneez
fever
wheez
occur
young
infant
symptom
may
irrit
decreas
activ
apnea
adult
present
similar
communityacquir
pneumonia
may
symptom
upper
respiratori
infect
less
day
prior
symptom
upper
respiratori
infect
rhinorrhea
sore
throat
cough
headach
fatigu
fever
physic
examin
target
follow
area
gener
appear
vital
sign
head
eye
ear
nose
throat
cardiac
pulmonari
thorax
gener
appear
vital
sign
import
discern
sever
ill
patient
letharg
confus
patient
tachycard
hypotens
sign
sever
ill
like
requir
hospit
examin
head
eye
ear
nose
throat
provid
evid
preced
upper
respiratori
infect
would
indic
viral
etiolog
cardiac
examin
new
gallop
murmur
indic
increas
sever
ill
pulmonari
thorax
examin
done
look
abnorm
breath
sound
evid
consolid
effus
indic
higher
level
sever
tabl
medic
given
base
etiolog
viral
pneumonia
influenza
treat
oseltamivir
herp
simplex
varicellazost
treat
acyclovir
antivir
treatment
proven
valu
avail
viral
pneumonia
high
clinic
suspicion
bacteri
superinfect
maintain
rsv
infect
highrisk
infant
young
children
like
benefit
immunoprophylaxi
base
gestat
age
certain
underli
medic
condit
rsv
season
palivizumab
avail
monoclon
antibodi
given
monthli
intramuscular
inject
rsv
season
prevent
use
standard
precaut
droplet
precaut
least
day
recommend
wash
hand
frequent
correctli
soap
water
least
use
alcoholbas
hand
gel
use
respiratori
hygien
measur
mask
tissu
cover
mouth
patient
respiratori
ill
avoid
share
cup
utensil
clean
contamin
surfac
yearli
influenza
vaccin
recommend
vaccin
contraind
antivir
chemoprophylaxi
recommend
encourag
patient
alert
provid
present
visit
symptom
respiratori
infect
tuberculosi
caus
mycobacterium
tuberculosi
mtb
larg
nonmotil
rodshap
oblig
aerob
bacterium
requir
oxygen
surviv
commonli
introduc
bodi
inhal
droplet
nuclei
mtb
usual
found
wellaer
upper
lobe
lung
mtb
facult
intracellular
parasit
engulf
macrophag
mtb
releas
alveoli
upon
death
macrophag
health
host
immun
system
key
factor
express
tb
diseas
onethird
world
popul
infect
tuberculosi
tb
nearli
nine
million
peopl
around
world
becam
sick
tb
diseas
approxim
million
tbrelat
death
worldwid
tb
lead
killer
peopl
hiv
infect
total
tb
case
per
person
report
unit
state
mtb
may
clear
host
immun
system
may
progress
latent
tb
infect
primari
tb
latent
tuberculosi
infect
ltbi
mean
host
immun
system
use
cellular
immun
system
mediat
thelper
cell
contain
mtb
granuloma
person
ltbi
risk
progress
activ
tb
diseas
immunocompromis
person
hiv
cancer
immunosuppress
medic
greater
risk
progress
activ
tb
diseas
center
diseas
control
cdc
recommend
highrisk
popul
screen
latent
infect
includ
hiv
patient
iv
drug
user
healthcar
worker
serv
highrisk
popul
contact
individu
pulmonari
tuberculosi
valid
riskassess
questionnair
may
use
identifi
children
like
benefit
screen
classic
clinic
featur
pulmonari
tuberculosi
includ
chronic
cough
sputum
product
appetit
loss
weight
loss
fever
night
sweat
hemoptysi
extrapulmonari
tuberculosi
occur
patient
hivinfect
person
risk
activ
tuberculosi
increas
soon
infect
hiv
count
less
may
atyp
present
tuberculosi
subtl
infiltr
pleural
effus
hilar
lymphadenopathi
form
extrapulmonari
tuberculosi
count
less
pulmonari
find
may
absent
dissemin
tuberculosi
frequent
dissemin
tuberculosi
present
nonspecif
chronic
febril
ill
widespread
organ
involv
latent
infect
diagnos
use
tuberculin
skin
test
tst
interferongamma
releas
assay
igra
tst
small
amount
tuberculin
inject
dermi
skin
creat
small
pale
bump
day
tst
must
read
train
healthcar
worker
posit
reaction
indur
measur
millimet
peopl
previous
vaccin
bacillu
bcg
may
falseposit
tst
igra
measur
person
immun
reactiv
mtb
white
blood
cell
person
infect
mtb
releas
interferon
gamma
mix
antigen
deriv
mtb
igra
requir
singl
patient
visit
result
avail
within
h
vaccin
bcg
caus
falseposit
igra
test
howev
igra
expens
tst
activ
tuberculosi
infect
diagnos
use
sputum
microscopi
cultur
along
chest
radiographi
three
sputum
sampl
obtain
acidfast
bacilli
afb
addit
nucleic
acid
amplif
test
naat
complet
blood
count
electrolyt
also
order
sputum
cultur
sensit
smear
stain
facilit
identif
mycobacterium
speci
nucleic
acid
amplif
evalu
drug
sensit
cultur
may
take
week
tb
case
afb
smearneg
neg
cultur
chest
xray
often
normal
hilar
adenopathi
common
abnorm
found
much
case
hilar
chang
occur
week
skin
test
convers
find
often
resolv
within
first
year
detect
posit
skin
test
primari
tb
pleural
effus
also
common
activ
tb
infect
treatment
depend
whether
latent
activ
infect
diagnos
latent
infect
treat
isoniazid
mg
daili
least
month
prefer
month
altern
regimen
includ
isoniazid
mg
rifapentin
mg
weekli
month
rifampin
mg
daili
month
isoniazid
mg
plu
rifampin
mg
daili
month
isoniazid
mg
plu
rifampin
mg
twice
weekli
month
treatment
regimen
requir
directli
observ
therapi
person
employ
state
health
depart
administ
ensur
patient
diagnos
latent
infect
take
medic
activ
tb
treat
fourdrug
regimen
isoniazid
rifampin
ethambutol
pyrazinamid
month
intens
phase
follow
isoniazid
rifampin
month
continu
phase
pyridoxin
supplement
recommend
prevent
isoniazidinduc
neuropathi
multidrugresist
diseas
initi
treatment
base
local
diseas
pattern
pend
drugsuscept
result
latergener
fluoroquinolon
prefer
eg
moxifloxacin
levofloxacin
activ
tb
sputum
analysi
done
weekli
sputum
convers
document
patient
receiv
pyrazinamid
undergo
baselin
period
serum
uric
acid
assess
receiv
longterm
ethambutol
therapi
undergo
baselin
period
visual
acuiti
redgreen
color
percept
test
also
patient
monitor
toxic
baselin
period
liver
enzym
complet
blood
cell
count
serum
creatinin
current
newli
diagnos
mtb
case
resist
one
firstlin
agent
isoniazid
commonli
associ
resist
strain
resist
isoniazid
rifampin
world
health
organ
estim
new
tb
case
multidrug
resist
tuberculosi
requir
report
local
public
health
author
control
pulmonari
tuberculosi
control
infect
effici
achiev
prompt
specif
drug
treatment
take
week
vital
organ
disappear
sputum
week
clear
sputum
patient
sputum
smearposit
tb
live
congreg
set
place
airborn
infect
isol
room
neg
pressur
ventil
patient
cover
nose
mouth
sneez
person
enter
room
tb
patient
resid
wear
person
respiratori
protect
devic
capabl
filter
particl
less
diamet
patient
whose
sputum
neg
bacteria
cough
known
adequ
drug
treatment
requir
isol
handwash
good
housekeep
practic
must
maintain
accord
polici
histoplasmosi
pulmonari
infect
caus
histoplasma
fungu
found
soil
larg
amount
bird
bat
guano
peopl
acquir
histoplasmosi
breath
microconidia
microspor
air
often
particip
activ
disturb
soil
although
peopl
breath
spore
becom
mildli
ill
moder
infect
may
present
fever
cough
andor
fatigu
everi
person
infect
spore
becom
ill
patient
weaken
immun
system
infect
becom
sever
especi
becom
system
infect
anyon
suscept
histoplasmosi
live
travel
area
histoplasma
live
soil
unit
state
histoplasma
mainli
live
soil
central
eastern
state
especi
ohio
mississippi
river
valley
histoplasma
report
worldwid
local
foci
locat
central
america
europ
africa
asia
outdoor
activ
often
associ
fungu
includ
cave
spelunk
mine
constructiondemolit
excav
chimney
clean
farminggarden
specif
popul
higher
risk
develop
sever
form
histoplasmosi
popul
includ
patient
weaken
immun
respons
hivaid
previou
organ
transplant
chronic
immunesuppress
medic
infant
older
adult
older
major
patient
either
symptom
present
subacut
influenzalik
symptom
dri
cough
fever
myalgia
fatigu
possibl
week
month
exposur
patient
acut
ill
present
symptom
includ
high
fever
headach
nonproduct
cough
chill
weak
pleurit
chest
pain
fatigu
patient
immunocompromis
increas
risk
system
dissemin
patient
live
area
highest
incid
travel
activ
histori
import
factor
diagnos
ill
gener
physic
exam
find
acut
pulmonari
infect
similar
bacteri
pneumonia
tachycardiatachypnea
hypoxiadecreas
adventiti
breath
soundsfev
possibl
septic
appear
initi
present
resembl
communityacquir
pneumonia
therefor
typic
lab
test
imag
complet
time
includ
cbc
chest
xray
base
initi
exam
diagnost
find
alon
patient
like
treat
bacteri
cap
patient
condit
worsen
initi
antibiot
therapi
fail
addit
special
test
complet
chest
xray
find
acut
pulmonari
histoplasmosi
includ
patchi
diffus
reticulonodular
infiltr
ct
scan
show
mediastin
hilar
lymphadenopathi
point
test
treatment
plan
adjust
recommend
definit
test
histoplasmosi
requir
cultur
growth
organ
take
week
sever
test
avail
diagnosi
histoplasmosi
consid
caus
ill
tabl
provid
list
test
avail
patient
present
diffus
diseas
chronic
diseas
cavit
lesion
hiv
test
differenti
caus
immunocompromis
state
complet
pneumonia
bacteri
atyp
viralsarcoidosisoth
pulmonari
fungal
infect
blastomycosi
aspergillosi
coccidioidomycosislung
cancer
tabl
summar
recent
recommend
treatment
histoplasmosi
recent
chang
treatment
recommend
increas
use
itraconazol
amphotericin
b
still
highli
recommend
patient
sever
pulmonari
histoplasmosi
immunosuppress
patient
patient
immunocompromis
educ
highrisk
behavior
endem
area
cave
explorationspelunk
exampl
provid
coccidioid
dimorph
fungu
found
soil
southwest
region
unit
state
coccidioidomycosi
infect
caus
coccidioid
immiti
coccidioid
posadasii
due
inhal
spore
incid
report
coccidioidomycosi
increas
per
popul
per
report
endem
area
arizona
california
nevada
new
mexico
utah
due
popul
increas
arizona
california
number
infect
risen
per
year
also
known
valley
fever
infect
usual
acquir
inhal
spore
live
around
endem
region
southwestern
unit
state
commonli
coccidioidomycosi
usual
present
selflimit
acut
subacut
communityacquir
pneumonia
develop
around
week
infect
patient
present
respiratori
complaint
fatigu
arthralgia
patient
fatigu
last
week
month
patient
infect
may
develop
progress
pulmonari
dissemin
infect
skin
mening
bone
person
african
filipino
descent
pregnant
diabet
immunosuppress
patient
higher
risk
extrapulmonari
complic
obtain
accur
travel
histori
import
patient
expos
region
exposur
possibl
southwestern
unit
state
common
symptom
respiratori
ill
particularli
involv
lower
respiratori
tract
ie
pneumonia
sever
ill
vari
mild
respiratori
infect
progress
pulmonari
lesion
dissemin
diagnosi
coccidioidomycosi
caus
difficult
without
test
sputum
cultur
grow
coccidioid
speci
establish
diagnosi
howev
could
take
week
cultur
grow
coccidioid
speci
consid
center
diseas
control
cdc
select
agent
specif
guidelin
overse
handl
usual
cultur
reserv
patient
requir
hospit
patient
ambulatori
set
serolog
test
use
diagnos
coccidioidomycosi
igm
igg
anticoccidioid
antibodi
usual
screen
test
choic
common
chest
radiograph
abnorm
airspac
opac
patient
follow
pulmonari
nodul
cavitari
lesion
risk
factor
evid
extens
coccidioid
infect
major
patient
need
antifung
medic
followup
visit
everi
month
year
recommend
serial
chest
radiograph
done
document
radiograph
resolut
identifi
extrapulmonari
complic
patient
present
sever
ill
risk
factor
ie
pregnanc
recommend
start
antifung
therapi
common
antifung
use
ketoconazol
mg
po
per
osbi
mouth
daili
fluconazol
mg
po
daili
itraconazol
mg
po
two
three
time
per
day
pregnant
patient
amphotericin
b
deoxychol
mgkg
intraven
daili
altern
day
amphotericin
b
lipid
formul
mgkg
greater
intraven
daili
use
antifung
choic
depend
sever
durat
therapi
rang
month
year
dust
control
measur
endem
area
face
mask
aircondit
cab
wet
soil
recommend
concurr
disinfect
discharg
soil
surfac
termin
clean
must
accomplish
legionnair
diseas
waterborn
pulmonari
infect
caus
gramneg
nonsporeform
aerob
bacterium
legionella
pneumophila
pulmonari
infect
coin
legionnair
outbreak
pneumonia
occur
peopl
attend
convent
american
legion
philadelphia
legionella
third
common
caus
pneumonia
immunocompet
patient
bacterium
legionella
pneumophila
love
warm
water
found
natur
environ
bacterium
live
spread
human
hot
tub
cool
tower
hot
water
tank
larg
plumb
system
fountain
bacteria
resid
droplet
water
vapor
mist
inhal
environ
contain
water
featur
describ
incub
period
usual
day
patient
notic
symptom
organ
suspect
patient
progress
pneumonialik
symptom
resist
standard
treatment
cap
sinc
discov
estim
peopl
hospit
yearli
unit
state
infect
consid
second
common
pathogen
detect
case
pneumonia
requir
admiss
icu
third
common
caus
pneumonia
immunocompet
patient
past
year
notabl
increas
number
case
report
infect
often
report
fall
summer
peak
august
mani
symptom
associ
legionnair
diseas
symptom
consist
report
includ
fever
loss
appetit
dyspnea
cough
headach
malais
patient
report
diarrhea
confus
phlegm
andor
bloodstreak
sputumhemoptysi
case
symptom
abrupt
start
recogn
treat
appropri
mild
infect
rapidli
turn
fatal
addit
inform
glean
patient
recent
travel
histori
includ
hotel
cruis
ship
stay
within
week
onset
symptom
physic
exam
find
might
includ
tachypnea
rr
mental
statu
chang
confusionral
auscultationrel
bradycardiagener
abdomin
tender
use
special
score
system
like
modifi
winthropunivers
hospit
infecti
diseas
divis
weight
point
system
diagnos
legionnair
diseas
adult
crucial
earli
infect
diagnos
correctli
treatment
legionnair
diseas
chest
xray
patient
legionella
pneumonia
appear
ident
xray
type
bacteri
pneumonia
therefor
addit
test
requir
gener
patient
admit
hospit
standard
blood
work
collect
cbc
bmp
blood
cultur
sputum
cultureg
stain
legionella
suspect
sever
option
test
organ
choic
test
like
driven
avail
within
clinic
hospit
laboratori
legionnair
diseas
suspect
urinari
antigen
test
legionella
cultur
respiratori
specimen
order
cultur
requir
special
medium
buffer
charcoal
yeast
extract
agar
bcye
gold
standard
sensit
test
isol
organ
cultur
sputum
bal
disadvantag
cultur
legionella
take
day
result
meticul
process
cultur
yield
sensit
specif
serum
test
develop
util
immunofluoresc
assay
ifa
enzymelink
immunosorb
assay
elisa
test
evalu
aid
diagnosi
antibodi
titer
increas
greater
fourfold
time
requir
adequ
test
use
method
take
week
sensit
specif
blood
serum
test
respect
newer
test
use
hospit
urinari
antigen
test
advantag
test
fast
turnaround
time
h
allow
shorter
time
present
diagnosi
target
treatment
main
disadvantag
use
test
detect
legionella
specif
l
pneumophila
serogroup
urinari
antigen
test
yield
sensit
specif
respect
bronchitisqfeveracut
respiratori
distress
syndromepneumonia
viral
atyp
bacterialpleur
effus
firstlin
treatment
legionella
pneumonia
follow
guidelin
bacteri
cap
util
either
respiratori
fluoroquinolon
azithromycin
tabl
immun
chemoprophylaxi
vaccin
avail
prevent
legionella
infect
import
factor
prevent
infect
continu
mainten
water
area
hot
tub
heatingcool
water
system
awar
outbreak
potenti
contamin
consid
multipl
case
within
commun
diagnos
legionella
mycobacterium
avium
complex
mac
consid
nontubercul
mycobacteria
mac
includ
sever
subspeci
mycobacterium
avium
subsp
avium
avium
subsp
silvaticum
avium
subsp
hominissui
avium
subsp
paratuberculosi
avium
subsp
intracellular
arosiens
chimaera
colombiens
marseillens
timonens
bouchedurhones
ituriens
nontubercul
mycobacteria
ntm
normal
inhabit
soil
water
infect
occur
occupi
habitat
share
human
anim
fish
poultri
habitat
includ
drink
water
distribut
system
household
plumb
patient
receiv
blocker
suscept
ntm
infect
mac
commonli
implic
symptom
nonspecif
patient
present
chronic
cough
without
sputum
product
hemoptysi
slowli
progress
fatigu
malais
constitut
symptom
weight
loss
fever
night
sweat
less
frequent
occur
patient
often
indic
advanc
diseas
physic
examin
would
type
pneumonia
radiograph
abnorm
specif
gener
follow
two
distinct
pattern
first
bronchiectasi
nodular
lesion
mostli
involv
lingual
middl
lobe
second
fibrocavitari
lesion
mostli
involv
upper
lobe
resembl
pulmonari
tuberculosi
differenti
diagnos
cavitari
lesion
includ
pulmonari
malign
sarcoidosi
infect
nonmycobacteri
pathogen
fungi
nocardia
speci
sputum
cultur
requir
make
diagnosi
least
two
separ
expector
sputum
sampl
least
one
bronchial
wash
lavag
treatment
regimen
consist
rifamycin
rifampin
rifabutin
ethambutol
macrolid
azithromycin
clarithromycin
therapi
given
daili
intermitt
depend
diseas
type
sever
nodular
bronchiectasi
pattern
usual
treat
three
time
weekli
therapi
cavitari
mac
diseas
involv
daili
threedrug
therapi
addit
im
streptomycin
imiv
amikacin
usual
given
three
time
weekli
pneumocysti
pneumonia
pcp
opportunist
infect
occur
immunocompromis
patient
person
infect
human
immunodefici
viru
hiv
patient
chronic
immunosuppress
therapi
also
risk
tradit
nomenclatur
organ
pneumocysti
carinii
pneumonia
p
c
arinii
pneumonia
name
chang
pneumocysti
jiroveci
distinguish
speci
affect
human
acronym
pcp
still
use
today
p
neumo
c
ysti
pneumonia
avoid
confus
medic
literatur
patient
acquir
immunodefici
syndrom
aid
pcp
common
opportunist
infect
sinc
introduct
highli
activ
antiretrovir
therapi
haart
preval
pcp
decreas
patient
typic
immunocompromis
state
develop
pneumocysti
pneumonia
risk
pcp
increas
thelper
cell
count
decreas
patient
pcp
usual
occur
count
less
symptom
includ
lowgrad
fever
progress
dyspnea
nonproduct
cough
upon
physic
examin
patient
may
tachycardia
tachypnea
auscult
lung
within
normal
limit
may
reveal
nonspecif
crackl
pcp
chest
radiograph
show
perihilar
interstiti
infiltr
may
becom
dispers
diseas
process
worsen
one
may
also
see
lung
nodul
chest
radiograph
normal
highresolut
comput
tomographi
ct
scan
may
show
groundglass
attenu
lesion
cystic
natur
diagnosi
pcp
induc
sputum
hyperton
salin
cultur
initi
test
choic
cultur
neg
still
suspect
bronchoscopi
bronchoalveolar
lavag
indic
acut
ill
patient
pcp
mmhg
treatment
choic
trimethoprimsulfamethoxazol
tmpsmx
mgkg
po
daili
divid
dose
patient
acut
ill
mmhg
unabl
take
po
corticosteroid
taper
ad
conjunct
tmpsmx
patient
take
prednison
mg
twice
daili
day
follow
mg
daili
day
mg
daili
day
patient
toler
tmpsmx
altern
regimen
includ
oral
primaquin
mg
daili
plu
clindamycin
mg
three
time
daili
atovaquon
mg
oral
twice
day
trimethoprim
mgkg
oral
three
time
daili
plu
dapson
mg
oral
daili
pentamidin
mgkg
intraven
daili
dehydrogenas
defici
must
check
prior
use
primaquin
dapson
durat
treatment
day
follow
therapi
recommend
patient
start
pcp
prophylaxi
patient
hiv
primari
prophylaxi
start
count
less
prophylact
treatment
choic
tmpsmx
one
tablet
singl
doubl
strength
mouth
daili
option
includ
dapson
mg
po
daili
atovaquon
mg
po
daili
pentamidin
mg
po
nebul
everi
week
introduct
haart
prophylaxi
discontinu
level
go
